Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

PROCEPT BioRobotics (PRCT) Interest Expenses (2020 - 2026)

PROCEPT BioRobotics has reported Interest Expenses over the past 7 years, most recently at $818000.0 for Q1 2026.

  • Quarterly Interest Expenses fell 6.73% to $818000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Mar 2026, down 12.2% year-over-year, with the annual reading at $3.6 million for FY2025, 14.29% down from the prior year.
  • Interest Expenses was $818000.0 for Q1 2026 at PROCEPT BioRobotics, down from $894000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $1.5 million in Q3 2022 and troughed at $818000.0 in Q1 2026.
  • The 5-year median for Interest Expenses is $969000.0 (2024), against an average of $1.0 million.
  • Year-over-year, Interest Expenses crashed 39.86% in 2022 and then grew 29.91% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $866000.0 in 2022, then grew by 29.91% to $1.1 million in 2023, then decreased by 13.87% to $969000.0 in 2024, then dropped by 7.74% to $894000.0 in 2025, then dropped by 8.5% to $818000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Interest Expenses are $818000.0 (Q1 2026), $894000.0 (Q4 2025), and $919000.0 (Q3 2025).